In March 2015 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4071 (the Athlete) after his sample tested positive for the prohibited substance tulobuterol. After notification a provisional suspension was ordered and the Athlete filed a statement in his defence.
The Athlete submitted that he suffered from asthma and used the prescribed medication Hokunalin with a TUE and without intention to enhance his sport performance. The Panel finds that the Athlete’s doctor had no special knowledge about anti-doping rules and prohibited substances and the Athlete assumed that the prescribed medication did not contain prohibited substances, also because it is not an oral medication.
Considering the circumstances in this case the Japan Anti-Doping Disciplinary Panel decides on 21 April 2015 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 25 March 2015.
